For patients and caregivers navigating US coverage and costs
What this page helps you do
Check insurance, tax-favored account rules, legitimate assistance, supplier terms, and the full cost before financing; avoid cure claims and pressure sales.
- Your task
- Organize the information, priorities, and next review needed for a real-world decision.
- The clinician boundary
- The clinical office owns patient-specific medical documentation; the plan owns its current coverage rule and decision. SteadySkin does not represent you.
What cost should I compare?
Compare the total path, not only a sticker price: visits, treatment or device, supplies, travel, time, training, support, maintenance, repairs, returns, and what happens if the plan changes. Confirm which costs are estimates and which are written obligations. Evidence
Why this item matters
Clinic and home care distribute costs differently, and device ownership creates a longer support tail. Coverage can also depend on benefit and supplier rules.
Can I use an HSA or FSA?
You may be able to use a health savings account (HSA) or flexible spending account (FSA). Current tax rules and the exact expense decide eligibility. Check before buying and keep the required records. Evidence
Why this item matters
IRS guidance distinguishes qualifying medical care from expenses that are merely beneficial to general health and warns against receiving both reimbursement and a duplicate deduction.
What should I verify about manufacturer or assistance programs?
Verify who operates the program, eligibility, which costs it covers, expiration, privacy terms, renewal, what happens if coverage changes, and whether participation affects the supplier or pharmacy route. Treat current written terms as controlling. Evidence
Why this item matters
Programs can change and may exclude public coverage or particular uses. A prior-authorization support service is not the same as coverage or a clinical recommendation.
Should I finance a device or treatment?
Financing changes when you pay, not whether the treatment is appropriate, effective, supported, or affordable over time. Review the full repayment obligation, fees, return policy, ownership, service, and what happens if you stop treatment before signing. Evidence
Why this item matters
A seller, lender, manufacturer, supplier, and insurer can have different interests and responsibilities. A payment approval is not insurance authorization.
Questions that can change the next decision
- For the supplierWhat happens if the device breaks?Saving keeps this on your device and needs JavaScript, which is off in this browser.
- For your health planWhat would I owe if I stop using it?Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- U.S. Department of Labor, Employee Benefits Security AdministrationRegulatory / guideline · independentIndependent source
- Published
- 2026-07-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports that participants in ERISA-covered plans receive or may request important plan documents, including the summary plan description, and that written requests can matter.
What it does not support
It does not apply identically to every coverage regime, interpret a specific plan, establish coverage for phototherapy, or provide legal advice.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- HealthCare.gov, U.S. Centers for Medicare & Medicaid ServicesRegulatory / guideline · independentIndependent source
- Published
- 2026-07-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports a general US individual and group health-plan distinction between internal appeal and eligible external review, and the need to use the denial notice for instructions.
What it does not support
Rights, deadlines, urgent pathways and external-review availability vary by plan and jurisdiction, so this source does not supply a universal deadline or guarantee review.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- U.S. Centers for Medicare & Medicaid ServicesRegulatory / guideline · independentIndependent source
- Published
- 2026-04-13
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports current Medicare context that DMEPOS orders use standardized elements and that supporting documentation is beneficiary-specific.
What it does not support
It does not establish that a home phototherapy device is covered, identify a code, apply to commercial plans, or replace the current plan and supplier requirements.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- U.S. Internal Revenue ServiceRegulatory / guideline · independentIndependent source
- Published
- 2026-01-15
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports general federal tax context that qualifying medical expenses may be eligible for certain tax-favored health accounts and that reimbursement and deduction cannot be duplicated.
What it does not support
It does not determine whether a specific phototherapy purchase qualifies, interpret a person’s plan document, or provide tax advice.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.